Article info
Uterine Cancer
Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines
- Address correspondence and reprint requests to Amber Yasmeen, PhD, Segal Cancer Center, Lady Davis Institute of Medical Research, McGill University, 3755 Cote Ste, Catherine Rd, Montreal, QC, Canada H3T 1E2. E-mail: amber.yasmeen@mail.mcgill.ca.
Citation
Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines
Publication history
- Received January 6, 2016
- First published September 1, 2016.
Online issue publication
January 27, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2016 by IGCS and ESGO